KIDNEY - CONTROL OF HOMEOSTASIS - Siwss National Centre of Competence in Research open the menu close the menu

News & Events

See the latest news from the NCCR Kidney.CH below.

The NCCR also regularly organizes educational, networking and outreaching events. Information on upcoming and past events of the NCCR Kidney.CH and other organizers can be found below. Please use the drop-down menu to confine your search.

  • News

    News

    • 12 October 2020

      Electrophysiology Facility launches

      In a joint effort of the Department of Molecular Life Sciences of UZH and the Institute of Anatomy, as well as the Clinic of Endocrinology, Diabetology and Clinical Nutrition from the USZ and the National Center of Competence in Research (NCCR) Kidney.CH, we have launched the Electrophysiology Facility (e-phac).

      more Details

    • 9 September 2020

      Cancer drug can rebalance kidney function in a devastating genetic disease

      Researchers at the University of Cambridge and the University of Zurich, including NCCR member Olivier Devuyst, have discovered that a drug newly approved for cancer improves kidney dysfunction in a mouse model of Dent disease 2 and Lowe syndrome.

      more Details

    • 2 July 2020

      NCCR member contributes to Science paper on uromodulin

      NCCR scientist & uromodulin expert Olivier Devuyst contributed to this Science paper on how #uromodulin helps fight off urinary tract infections.

      more Details

    • 23 June 2020

      NCCR scientists perform high-resolution imaging of calcium ion signaling in kidney cells

      A group of scientists at the University of Zurich, including the NCCR's own Andrew Hall, has shown that it is possible to perform imaging of Ca2+ signals at high resolution in the mouse kidney in vivo.

      more Details

    • 27 Mai 2020

      New X-ray contrast agent developed by UZH and NCCR researchers

      Researchers at the universities of Basel and Zurich, including Vartan Kurtcuoglu of the NCCR Kidney.CH, have developed a novel X-ray contrast agent called “XlinCA”.

      more Details

  • All Events

    All Events

  • Symposium 2021

    Symposium 2021

  • Retreat 2021

    Retreat 2021

x

9 September 2020

Cancer drug can rebalance kidney function in a devastating genetic disease

Researchers at the University of Cambridge and the University of Zurich, including NCCR member Olivier Devuyst, have discovered that a drug newly approved for cancer improves kidney dysfunction in a mouse model of Dent disease 2 and Lowe syndrome.

The study was recently published in Kidney International and offers hope for the first disease-modifying treatment. In addition to kidney dysfunction, characteristic of Dent disease 2, boys with Lowe syndrome also require eye cataract surgery as newborns, and suffer seizures and other disabilities. Only supportive treatments are available, such as nutrient supplements and help with learning.

Read the full paper here.